On CNBC’s "Halftime Report Final Trades," Bryn Talkington of Requisite Capital Management named SPDR S&P Biotech ETF XBI, which is trading in a tight range between $75 and $90.
Josh Brown of Ritholtz Wealth Management said iShares U.S. Aerospace & Defense ETF ITA, is a couple of dollars away from breaking its pre-COVID high.
Don’t forget to check out our premarket coverage here
Jim Lebenthal of Cerity Partners said Thermo Fisher Scientific Inc. TMO is a "high-quality company" in the healthcare space.
Thermo Fisher Scientific is scheduled to host Investor Day on May 24 at 9:00 a.m. ET.
Benzinga's analyst ratings data finds a consensus Buy rating on TMO.
Rob Sechan of New Edge Capital Group picked Principal Financial Group, Inc. PFG, saying that it is a "cheap way" to play financials.
Principal Financial is expected to release Q1 financial results after the closing bell on April 27, 2023.
Price Action: Thermo Fisher Scientific shares rose 2% to close at $591.13, while Principal Financial fell 0.4% to settle at $75.07 on Thursday. The SPDR S&P Biotech ETF gained 4.4% to $79.43, while iShares U.S. Aerospace & Defense ETF rose 0.5% to $116.89 on Thursday.
Check This Out: Over $1M Bet On This Real Estate Stock? Check Out These 3 Stocks Insiders Are Buying
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
